New Edge Advisors, LLC Gain Therapeutics, Inc. Call Options Transaction History
New Edge Advisors, LLC
- $11.2 Billion
- Q1 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding GANX
# of Institutions
33Shares Held
2.58MCall Options Held
22.2KPut Options Held
16K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$753,1640.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$724,6460.1% of portfolio
-
Raymond James & Associates St Petersburg, FL260KShares$332,8240.0% of portfolio
-
Royal Bank Of Canada Toronto, A6249KShares$318,0800.0% of portfolio
-
Geode Capital Management, LLC Boston, MA177KShares$226,6760.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $15.2M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...